Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

Journal of Clinical Investigation

Volumn 109, Issue 3, 2002, Pages 317-325

  Worlitzsch, Dieter ^a   Tarran, Robert ^b   Ulrich, Martina ^a   Schwab, Ute ^b   Cekici, Aynur ^a   Meyer, Keith C ^c   Birrer, Peter ^d   Bellon, Gabriel ^e   Berger, Jürgen ^f   Weiss, Tilo ^a   Botzenhart, Konrad ^a   Yankaskas, James R ^b   Randell, Scott ^b   Boucher, Richard C ^b   Döring, Gerd ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f MAX PLANCK INSTITUTE FOR DEVELOPMENTAL BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTIBIOTIC AGENT; OXYGEN;

ADULT; AIRWAY; ANAEROBIC GROWTH; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BRONCHUS MUCUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN VITRO STUDY; LUNG FLUID; LUNG INFECTION; MALE; OXYGEN CONCENTRATION; OXYGEN CONSUMPTION; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION;

EID: 0036167851     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0213870     Document Type: Article

References (44)

1. Cystic fibrosis
2. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis
3. Immunology of cystic fibrosis
4. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells
5. Receptors in the Pseudomonas aeruginosa adherence to injured and repairing airway epithelium
6. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections
7. Cystic fibrosis
8. Chromosomal genetics of Pseudomonas
9. Localization of Staphylococcus aureus in infected airways of patients with cystic fibrosis and in a cell culture model of S. aureus adherence
10. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease
11. The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition
12. Thin-film measurements of airway surface liquid volume/composition and mucus transport rates in vitro
13. Isolation and assay of Pseudomonas aeruginosa alginate
14. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis
15. The pathogenesis of fibrocystic disease of the pancreas. A study of 36 cases with special reference to the pulmonary lesions
16. Coordinated clearance of periciliary liquid and mucus from airway surfaces
17. Primary ciliary dyskinesia (the immotile cilia syndrome)
18. Growth of Pseudomonas aeruginosa on nitrous oxide
19. Comparison of denitrification by Pseudomonas stutzeri, Pseudomonas aeruginosa, and Paracoccus denitrificans
20. Anaerobic production of alginate by Pseudomonas aeruginosa: Alginate restricts diffusion of oxygen
21. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis
22. Nitric oxide metabolites in cystic fibrosis lung disease
23. Nasal contribution to exhaled nitric oxide at rest and during breathholding in humans
24. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome
25. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid
26. Quantitation of adherence of mucoid and nonmucoid Pseudomonas aeruginosa to hamster tracheal epithelium
27. Comparison of bacterial adherence to ciliated and squamous epithelial cells obtained from the human respiratory tract
28. Evidence for mucins and sialic acid as receptors for Pseudomonas aeruginosa in the lower respiratory tract
29. Surface morphology of human airway mucosa: Normal, carcinoma, or cystic fibrosis
30. Scanning electron microscopic study of the airways in normal children and in patients with cystic fibrosis and other lung diseases
31. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration
32. The CF salt controversy: In vivo observations and therapeutic approaches
33. + transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation
34. Altered fluid transport across airway epithelium in cystic fibrosis
35. CFTR as a cAMP-dependent regulator of sodium channels
36. Oxygen consumption and ouabain binding sites in cystic fibrosis nasal epithelium
37. +ATPase in lower airway epithelium from cystic fibrosis and non-cystic-fibrosis lung
38. 2) and ouabain binding in cystic fibrosis (CF) and normal nasal epithelium
39. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis
40. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen
41. Oxygen tensions and infections: Modulation of microbial growth, activity of antimicrobial agents, and immunologic responses
42. 2 tension on microbicidal function of leukocytes in wounds and in vitro
43. Mucus clearance as a primary innate defense mechanism for mammalian airways